Back to mobile site
Get it on Google Play

Biofrontera completes transfer of Ameluz and RhodoLED FDA approvals

December 18, 2025 8:45 AM EST Send to a Friend
Biofrontera Inc. (NASDAQ: BFRI) completed the transfer of FDA approvals for its Ameluz and RhodoLED Lamp Series products, including the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login